SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-17-003100
Filing Date
2017-11-14
Accepted
2017-11-14 16:02:12
Documents
2
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 AURINIA PHARMACEUTICALS INC. 6-K a51715104.htm 6-K 13146
2 EXHIBIT 99.1 a51715104_ex991.htm EX-99.1 55463
  Complete submission text file 0001157523-17-003100.txt   69607
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 171201337
SIC: 2834 Pharmaceutical Preparations